CD103 Expression on Blastic Plasmacytoid Dendritic Cell Neoplasms in Peripheral Blood and Bone Marrow Samples
<p>Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) is an aggressive neoplasm which is typically CD4+, CD56+, and CD123+. There is limited information regarding CD103 expression on blastic plasmacytoid dendritic cell neoplasms. We identified six cases of BPDCN and all six had at least part...
Saved in:
Main Authors: | Ron Lee (Author), Sally Ullery (Author), Ron Thomason (Author) |
---|---|
Format: | Book |
Published: |
Archives of Hematology Case Reports and Reviews - Peertechz Publications,
2020-05-01.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Blastic plasmacytoid dendritic cell neoplasm
by: André Lencastre, et al.
Published: (2013) -
Juvenile Blastic Plasmacytoid Dendritic Cell Neoplasm
by: Kinan M. Hayani, et al.
Published: (2020) -
Blastic Plasmacytoid Dendritic Cell Neoplasm on the Scalp
by: Sawako Fukushi, et al.
Published: (2011) -
Blastic plasmacytoid dendritic cell neoplasm mimicking dermatomyositis
by: Christopher J. Fay, BA, et al.
Published: (2023) -
Blastic Plasmacytoid Dendritic Cell Neoplasm: A Case Report
by: Jian Hu, et al.
Published: (2019)